Dr. Lal PathLabs (NSE:LALPATHLAB) Interest Expense: ₹-244 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LALPATHLAB Dr. Lal PathLabs Ltd NSE:LALPATHLAB
97 GF Score
Price ₹1,894.20
GF Value ₹1,755.35
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Dr. Lal PathLabs Interest Expense?

Dr. Lal PathLabs NSE:LALPATHLAB +0.25% 97 Interest Expense is ₹-244 Mil as of Jun. 2026. GuruFocus rates NSE:LALPATHLAB with a GF Score™ of 97/100 and a GF Value™ of ₹1,755.35 (Fairly Valued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Dr. Lal PathLabs's interest expense for the three months ended in Jun. 2026 was ₹ -63 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹-244 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Dr. Lal PathLabs's Operating Income for the three months ended in Jun. 2026 was ₹ 2,031 Mil. Dr. Lal PathLabs's Interest Expense for the three months ended in Jun. 2026 was ₹ -63 Mil. Dr. Lal PathLabs's Interest Coverage for the quarter that ended in Jun. 2026 was 32.24. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dr. Lal PathLabs  (NSE:LALPATHLAB) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dr. Lal PathLabs's Interest Expense for the three months ended in Jun. 2026 was ₹-63 Mil. Its Operating Income for the three months ended in Jun. 2026 was ₹2,031 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2026 was ₹0 Mil.

Dr. Lal PathLabs's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2026 )/Interest Expense (Q: Jun. 2026 )
=-1*2031/-63
=32.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Dr. Lal PathLabs Interest Expense Historical Data

* Premium members only.

The historical data trend for Dr. Lal PathLabs's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Lal PathLabs Interest Expense Chart

Dr. Lal PathLabs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -302.00 -375.33 -293.59 -223.05 -228.00

Dr. Lal PathLabs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.00 -48.00 -72.00 -61.00 -63.00
NSE:LALPATHLAB
97GF Score
Dr. Lal PathLabs Ltd NSE:LALPATHLAB
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Lal PathLabs Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-244 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹-244 Mil mean?
Dr. Lal PathLabs (NSE:LALPATHLAB) has a Interest Expense of ₹-244 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Dr. Lal PathLabs and its competitors.
Is Dr. Lal PathLabs' Interest Expense too high?
Dr. Lal PathLabs' current Interest Expense is ₹-244 Mil. Overall, Dr. Lal PathLabs has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Lal PathLabs' Interest Expense compare to TMO and DHR?
Dr. Lal PathLabs' Interest Expense of ₹-244 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Diagnostics & Research company?
A good Interest Expense depends on the Medical Diagnostics & Research industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Dr. Lal PathLabs and its competitors. Dr. Lal PathLabs's current Interest Expense is ₹-244 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Lal PathLabs stock overvalued right now?
Based on GuruFocus' analysis, Dr. Lal PathLabs (NSE:LALPATHLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,755.35, compared to a current price of ₹1,894.20 — trading 7.9% above its estimated fair value. The current Interest Expense is ₹-244 Mil. Dr. Lal PathLabs' overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Dr. Lal PathLabs (NSE:LALPATHLAB), the current Interest Expense is ₹-244 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Lal PathLabs stock appears to be overvalued. The current stock price of ₹1,894.20 is trading 7.9% above its estimated GF Value™ of ₹1,755.35. GuruFocus considers Dr. Lal PathLabs to be Fairly Valued.

Key valuation signals for NSE:LALPATHLAB:

  • Interest Expense: ₹-244 Mil
  • GF Value™: ₹1,755.35 vs. price of ₹1,894.20 (7.9% above fair value)
  • GF Score™: 97/100 with 5 warning signs

No single metric tells the full story. See the NSE:LALPATHLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Lal PathLabs Business Description

Other Exchanges 539524:India
Address 12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the areas of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist in preventing, monitoring, and treating diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
97GF Score

Get the complete analysis for NSE:LALPATHLAB

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,894.20
Price
₹1,755.35
GF Value